Skip to main content

Letter to Shareholders Regarding Rafarma Acquisition by R. & D. Biocogency Laboratories Inc.

Written by Customer Service on . Posted in Public Companies.

Ljubljana, Slovenia, Aug. 05, 2020 (GLOBE NEWSWIRE) — Rafarma Pharmaceuticals, Inc. OTC:(RAFA) presents the following letter to Rafarma shareholders from CEO Vladimir Dolgolenko:
To Our Shareholders:During these exciting times I wanted to reach out to our shareholders and clarify some questions I have received. As recently announced, there will be a change in control forthcoming for Rafarma. The change in control will not affect the current share structure of the company. There has been no dilution and there are no current plans for dilution or issuance of additional shares as part of this acquisition. Our acquirer, R&D Biocogency Laboratories Inc. (“Biocogency”), brings an enormous amount of potential and an already proven business model. As stated in our previous release, Biocogency’s 2019 revenues were approximately $73 million with profits at approximately $17 million. We intend to both harness and grow these profits and further our expansion throughout Europe and Asia.Thailand operations are continuing as planned and will only be improved with this new infusion of capital and more research opportunities. Our strategic partners are extremely excited with the progress that has been made in recent months.This is also the first of what we believe will be several merger and acquisition activities. As we acquire additional companies and facilities, we believe shareholder value will increase immensely. As CEO I want to thank shareholders for their patience and their trust in Rafarma. I believe we are building a strong company with unlimited potential as we move forward.Kinds regards,
Vladimir Dolgolenko,
CEO, Rafarma Pharmaceuticals, Inc.Forward-Looking Statements: This press release contains “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934. Except for historical matters contained herein, statements made in this press release are forward-looking statements. Without limiting the generality of the foregoing, words such as “may”, “will”, “to”, “plan”, “expect”, “believe”, “anticipate”, “intend”, “could”, “would”, “estimate,” or “continue”, or the negative other variations thereof or comparable terminology are intended to identify forward-looking statements. Forward-looking statements involve known and unknown risk, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Also, forward-looking statements represent our management’s beliefs and assumptions only as of the date hereof. Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in the Company’s filings with OTC Markets. Except as required by law, we assume no obligation to update these forward-looking statements publicly or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.For more information contact:
RAFARMA
(307) 429-2029

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.